Detalhe da pesquisa
1.
To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma.
Pediatr Blood Cancer
; 69(8): e29663, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373890
2.
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Lancet Oncol
; 23(11): 1354-1357, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328007
3.
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.
J Natl Cancer Inst
; 116(2): 200-207, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975877
4.
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 190: 112950, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441939
5.
Setting international standards for patient and parent involvement and engagement in childhood, adolescent and young adult cancer research: A report from a European Collaborative Workshop.
Cancer Rep (Hoboken)
; 5(6): e1523, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383382
6.
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Eur J Cancer
; 166: 145-164, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290915
7.
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 177: 120-142, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335782
8.
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 160: 112-133, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34840026
9.
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 173: 71-90, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863108
10.
Intercontinental collaboration in clinical trials for children and adolescents with cancer-A systematic review by ACCELERATE.
Cancer Med
; 10(23): 8462-8474, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687165
11.
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Eur J Cancer
; 157: 198-213, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536944
12.
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 136: 116-129, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688206
13.
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
J Clin Oncol
; 42(3): 253-257, 2024 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011605
14.
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children.
Eur J Cancer
; 110: 74-85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772656
15.
Orphan Drug Regulation: A missed opportunity for children and adolescents with cancer.
Eur J Cancer
; 84: 149-158, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28818704
16.
When Innovation and Commercialization Collide: A Patient Advocate View in Neuroblastoma.
J Clin Oncol
; 40(2): 120-126, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793201
17.
The RACE to accelerate drug development for children with cancer.
Lancet Child Adolesc Health
; 4(10): 714-716, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822672